
Real-World ctDNA Positivity Predicts Poorer Outcomes in Early Breast Cancer
Circulating tumor DNA (ctDNA) positivity was associated with increased risk of recurrence and worse overall survival (OS) in patients with early-stage breast cancer, irrespective of subtype, based on findings from a real-world analysis using data from the …